University Hospital Cardiac Device MR Registry: The Safety of MR Imaging in Patients With Implanted Cardiac Devices
- Conditions
- DefibrillatorPacemakerMRI
- Registration Number
- NCT02548819
- Lead Sponsor
- University Health Care System, Augusta, Georgia
- Brief Summary
A single-center registry to prospectively evaluate the safety of non-cardiac/non-thoracic magnetic resonance imaging (MRI) in patients with implanted cardiac devices (pacemakers and implantable cardioverter defibrillators).
- Detailed Description
Evaluation of safety of MR scanning of patients with implanted cardiac devices. Device parameters pre and post MR imaging will be assessed.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 220
- Male or female 18 years or older
- Informed consent can be provided by patient or medical power of attorney
- Presence of implanted pacemaker or ICD
- MRI is the diagnostic modality of choice for a specific clinical scenario without acceptable alternative imaging technology as determined by ordering physician
- Non-cardiac/non-thoracic MRI ordered
- Presence of metallic objects that represent a contraindication to MR imaging
- Morbid obesity which results in body contact with the magnet façade
- Pacemaker or ICD generator implanted prior to 2002
- ICD patients who are pacing dependent
- Pregnancy
- Device generator at ERI (elective replacement interval)
- Presence of other active implanted medical device
- Presence of abandoned leads (with the exception of post CABG temporary epicardial pacing wires)
- Presence of implanted cardiac device in the abdominal position
- Pacemaker or ICD that is labeled as MRI-Conditional by the FDA
- Pacemaker or ICD implanted less than 6 weeks prior to MRI scan
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Battery voltage Immediate Change in voltage \> 0.04 V
Pacing lead impedance Immediate Change in impedance \> 50 Ohms
Shock impedance Immediate Change in impedance \> 3 Ohms
P wave amplitude Immediate Decrease in amplitude \> 50%
R wave amplitude Immediate Decrease in amplitude \> 25%
Pacing lead threshold Immediate Threshold increase \> 0.5 V at a fixed pulse width of 0.4ms
Adverse event Immediate An adverse clinical event
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University Hospital
🇺🇸Augusta, Georgia, United States